Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that today Rosen’s Diversified, Inc. (“RDI”) declared that...
Elevates MIS posterior fixation optionality Robust instrumentation designed to treat more complex pathologies less invasively CARLSBAD, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated...
MONTREAL, Oct. 19, 2020 /PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) ("Ortho RTI" or the "Company"), an emerging orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced...
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral and knee-surgery implants, and SeaSpine Holdings...
Colson Medical, LLC is pleased to announce the merger of two Colson Medical companies, Acumed and OsteoMed. Operations will be integrated gradually over the coming year while maintaining both global...
SHELTON, Conn., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Spine Wave is pleased to announce the successful completion of its limited market release and the launch of the Salvo® 4.75 mm Spine...
CANTON, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the...
Solid upturn in equipment orders in Q3 2020 Strengthened cash position at €10.2m PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Euronext, FR0011191766 - EOSI - PEA-PME eligible) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and...
CARLSBAD, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced...
90% of patients show bone fusion as well as strong clinical improvements in function and pain at 24 months follow-up period with a good product safety profile Gosselies, Belgium, 14 October...